271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details
臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ITMCTR2200006601 | 2022-09-15 | 2022-09-15 | Observation of curative effect of Du-moxibustion on patients with active ankylosing spondylitis | Clinical evaluation and mechanism study of moxibustion on Du meridian in the treatment of active ankylosing spondylitis | ankylosing spondylitis | healthy group:Oral celecoxib;therapy group:Du-Moxibustion (Moxibustion of Governor Vessel); | Affiliated Hospital of Shandong University of Traditional Chinese Medicine | NULL | Recruiting | 18 | 60 | Both | healthy group:30;therapy group:30; | China | |
| 2 | ChiCTR2100051907 | 2021-12-07 | 2021-10-09 | Governor Vessel Moxibustion Therapy Improves Microbiota Structure in Ankylosing Spondylitis Patients | Governor Vessel Moxibustion Therapy Improves Microbiota Structure in Ankylosing Spondylitis Patients | Ankylosing spondylitis | Experimental group:Governor vessel moxibustion therapy treatment;Control group:Medical treatement; | The Affiliated Hospital of Shandong Academy of Medical Sciences | NULL | Pending | Male | Experimental group:15;Control group:15; | N/A | China | ||
| 3 | ChiCTR-TRC-13004564 | 2007-07-01 | 2013-07-05 | A 48 Week Randomized Controlled Trial to Evaluate the Clinical Outcomes of Ankylosing Spondylitis Managed by Chinese Medicine Compared with Western Medicine, a pilot study. | A 48 Week Randomized Controlled Trial to Evaluate the Clinical Outcomes of Ankylosing Spondylitis Managed by Chinese Medicine Compared with Western Medicine, a pilot study. | Ankylosing Spondylitis | CM:Decoction of Chinese herbs + Moxibustion on 'Governor Vessel (GV)' + standard AS exercise regimen;WM treatment group:Celecoxib 200mg twice daily + standard AS exercise regimen; | Guangdong Provincial Hospital of Chinese Medicine | NULL | Completed | 18 | 60 | Both | CM:15;WM treatment group:15; | I (Phase 1 study) | China |